(Q28254262)

12 December 2020

Influence of age on mianserin pharmacokinetics

1 reference

12 December 2020

Fluoxetine and norfluoxetine are potent inhibitors of P450IID6--the source of the sparteine/debrisoquine oxidation polymorphism

1 reference

12 December 2020

Pharmacogenetics of tricyclic and novel antidepressants: recent developments

1 reference

12 December 2020

Fluoxetine may antagonize the anxiolytic action of buspirone.

1 reference

12 December 2020

Accumulation of fluoxetine and norfluoxetine in human brain during therapeutic administration

1 reference

12 December 2020

Fluoxetine: a serotonin-specific, second-generation antidepressant

1 reference

12 December 2020

Increased carbamazepine plasma concentrations after fluoxetine coadministration

1 reference

12 December 2020

Classification and determination of cerebral bioavailability of fluoxetine: pharmacokinetic, pharmaco-EEG, and psychometric analyses

1 reference

12 December 2020

A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression

1 reference

12 December 2020

Does fluoxetine have a therapeutic window?

1 reference

12 December 2020

Manipulations of synaptic serotonin: discrepancy of effects on serotonin S1 and S2 sites.

1 reference

12 December 2020

Interaction between fluoxetine and neuroleptics

1 reference

12 December 2020

The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature

1 reference

12 December 2020

Fluoxetine: relationships among dose, response, adverse events, and plasma concentrations in the treatment of depression.

1 reference

12 December 2020

Decreased beta-adrenergic receptors in rat brain after chronic administration of the selective serotonin uptake inhibitor fluoxetine

1 reference

12 December 2020

Fluoxetine compared with amitriptyline in elderly depression: a controlled clinical trial

1 reference

12 December 2020

Clinical pharmacology and pharmacokinetics of fluoxetine: a review.

1 reference

12 December 2020

Report of a fluoxetine fatality

1 reference

12 December 2020

Inhibition by fluoxetine of cytochrome P450 2D6 activity.

1 reference

12 December 2020

Pharmacokinetics of antidepressants: why and how they are relevant to treatment

1 reference

12 December 2020

Fluoxetine and desipramine: a strategy for augmenting anti-depressant response

1 reference

12 December 2020

Fluoxetine: a review of receptor and functional effects and their clinical implications.

1 reference

12 December 2020

Interaction of fluoxetine with tricyclic antidepressants

1 reference

12 December 2020

Elevation of plasma concentrations of haloperidol after the addition of fluoxetine

1 reference

12 December 2020

Fluoxetine disposition and elimination in cirrhosis

1 reference

12 December 2020

Effect of fluoxetine on plasma desipramine and 2-hydroxydesipramine

1 reference

12 December 2020

Fluoxetine drug-drug interactions: I. Antidepressants and antipsychotics

1 reference

12 December 2020

Pharmacokinetics of second generation antidepressants: fluoxetine

1 reference

12 December 2020

Fluoxetine overdose: a case report

1 reference

12 December 2020

The use of antidepressants for long-term treatment of recurrent depression: rationale, current methodologies, and future directions.

1 reference

12 December 2020

Fluoxetine kinetics and protein binding in normal and impaired renal function

1 reference

12 December 2020

Solid-phase extraction of fluoxetine and norfluoxetine from serum with gas chromatography-electron-capture detection

1 reference

12 December 2020

Serum fluoxetine and norfluoxetine concentrations and antidepressant response

1 reference

12 December 2020

Trial of fluoxetine added to neuroleptics for treatment-resistant schizophrenic patients

1 reference

12 December 2020

Pharmacokinetic pharmacodynamic evaluation of the combined administration of alprazolam and fluoxetine.

1 reference

12 December 2020

Absence of hepatic cytochrome P450bufI causes genetically deficient debrisoquine oxidation in man

1 reference

12 December 2020

Quantification and mechanism of the fluoxetine and tricyclic antidepressant interaction

1 reference

12 December 2020

Effect of fluoxetine on psychomotor performance, physiologic response, and kinetics of ethanol

1 reference

12 December 2020

Serious adverse effects of combining fluoxetine and tricyclic antidepressants

1 reference

12 December 2020

The role of cytochrome P4502D6 in the metabolism of paroxetine by human liver microsomes

1 reference

12 December 2020

Pharmacokinetics of the selective serotonin reuptake inhibitors

1 reference

12 December 2020

Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness

1 reference

12 December 2020

Influence of fluoxetine on plasma levels of desipramine

1 reference

12 December 2020

The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes

1 reference

12 December 2020

Tissue concentrations of clozapine and its metabolites in the rat

1 reference

12 December 2020

Sensitive and selective liquid-chromatographic assay of fluoxetine and norfluoxetine in plasma with fluorescence detection after precolumn derivatization

1 reference

12 December 2020

Interaction of fluoxetine and pentazocine

1 reference

12 December 2020

A pharmacokinetic evaluation of the combined administration of triazolam and fluoxetine

1 reference

12 December 2020

Serotonin reuptake blockers in vitro and in vivo.

1 reference

12 December 2020

A preliminary study of serotonergic antidepressants in treatment of dysthymia

1 reference

12 December 2020

The relationship between paroxetine and the sparteine oxidation polymorphism

1 reference

12 December 2020

Determination of fluoxetine and norfluoxetine in plasma by gas chromatography with electron-capture detection

1 reference

12 December 2020

Serum concentrations of clozapine and its major metabolites: effects of cotreatment with fluoxetine or valproate

1 reference

12 December 2020

1 reference

12 December 2020

Extrapyramidal symptoms in a patient taking haloperidol and fluoxetine.

1 reference

12 December 2020

Clinical pharmacokinetics of selective serotonin reuptake inhibitors

1 reference

12 December 2020

Receptor alterations associated with serotonergic agents: an autoradiographic analysis

1 reference

12 December 2020

Possible adverse drug interactions between fluoxetine and other psychotropics

1 reference

12 December 2020

Fluoxetine inhibits desipramine metabolism

1 reference

12 December 2020

Clinical pharmacokinetics of tricyclic antidepressant overdose

1 reference

12 December 2020

Plasma-level response relationships with fluoxetine and zimelidine

1 reference

12 December 2020

Relationship between age and tricyclic antidepressant plasma levels

1 reference

12 December 2020

The evidence for 20mg a day of fluoxetine as the optimal dose in the treatment of depression

1 reference

12 December 2020

Drug-drug interactions of fluoxetine with tricyclics

1 reference

12 December 2020

Antidepressants, metabolites, and apparent drug resistance

1 reference

12 December 2020

Rapid down regulation of beta-adrenoceptors by co-administration of desipramine and fluoxetine

1 reference

12 December 2020

Fluoxetine: clinical pharmacology and physiologic disposition

1 reference

12 December 2020

The importance of blood collection site for the determination of basic drugs: a case with fluoxetine and diphenhydramine overdose.

1 reference

12 December 2020

Addition of fluoxetine to clozapine

1 reference

12 December 2020

The effect of fluoxetine on the pharmacokinetics and psychomotor responses of diazepam.

1 reference

12 December 2020

Drug-resistance phenomena in major psychoses: their discrimination and causal mechanisms.

1 reference

12 December 2020

Fluoxetine treatment of depression. Clinical effects, drug concentrations and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluid.

1 reference

12 December 2020

Fluoxetine impairs clearance of alprazolam but not of clonazepam

1 reference

12 December 2020